跳至主要内容
临床试验/CTRI/2024/10/075301
CTRI/2024/10/075301尚未招募不适用

Metformin for treatment of olanzapine induced weight gain in adult patients with schizophrenia

Shadithya hospital private limited1 个研究点 分布在 1 个国家目标入组 64 人开始时间: 2024年10月20日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
64
试验地点
1
主要终点
Weight

研究概览

简要总结

Title of the study

Metformin for the treatment of olanzapine induced weight gain in adult patients with schizophrenia

Objectives of the study

To determine the effect of Metformin in reducing Olanzapine-induced weight gain in patients with schizophrenia.

To find out the dose range of Metformin which is most effective in reducing weight gain in patients on olanzapine

Study design

Observational cohort study

Patients with schizophrenia newly started on Olanzapine along with Metformin (500-2000mg/day)

Follow up at 15 days, 30 days and 90 days

研究设计

研究类型
Interventional
分配方式
Na
盲法
None

入排标准

年龄范围
18.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • Patients diagnosed with Schizophrenia and newly started on Olanzapine.

排除标准

  • Patients not tolerating Metformin Patients with history of renal disease, diabetes.

结局指标

主要结局

Weight

时间窗: Weight at 15 days, 30 days and 90 days

次要结局

  • Waist circumference and Body mass index(Waist circumference and Body mass index at 15 days, 30 days and 90 days)

研究者

发起方
Shadithya hospital private limited
申办方类型
Private hospital/clinic
责任方
Principal Investigator
主要研究者

Dr Sreeprathap M

Department of psychiatry, Shadithya hospital

研究点 (1)

Loading locations...

相似试验

A clinical trial to study the effect of Metformin in... | 临床试验